Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Bioengineering
Link
https://link.springer.com/content/pdf/10.1007/s12668-022-00997-9.pdf
Reference145 articles.
1. Sayganov, S. A., Mazurov, V. I., Bakulin, I. G., et al. (2020). Current, effectiveness of therapy and outcomes of new coronavirus infection: Preliminary analysis. Journal of North-Western State Medical University named after I.I. Mechnikov, 12(2), 27–38. https://doi.org/10.17816/mechnikov34932
2. Zhang, Y., Li, J., Zhan, Y., et al. (2004). Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infection and Immunity, 72(8), 4410–4415. https://doi.org/10.1128/IAI.72.8.4410-4415.2004
3. Lau, S. K. P., Lau, C. C. Y., Chan, K. H., et al. (2013). Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment. Journal of General Virology, 94(Pt 12), 2679–2690. https://doi.org/10.1099/vir.0.055533-0
4. Tufan, A., AvanoğluGüler, A., & Matucci-Cerinic, M. (2020). COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci., 50(SI-1), 620–632. https://doi.org/10.3906/sag-2004-168
5. Wong, J. P., Viswanathan, S., Wang, M., Sun, L. Q., Clark, G. C., & D’Elia, R. V. (2017). Current and future developments in the treatment of virus-induced hypercytokinemia. Future Medicinal Chemistry, 9(2), 169–178. https://doi.org/10.4155/fmc-2016-0181
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diverging patterns in innate immunity against respiratory viruses during a lifetime: lessons from the young and the old;European Respiratory Review;2024-04-30
2. A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection;Nature Communications;2023-12-05
3. Complexity of the Immune Response Elicited by Different COVID-19 Vaccines, in the Light of Natural Autoantibodies and Immunomodulatory Therapies;International Journal of Molecular Sciences;2023-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3